Annovis Bio (ANVS) Projected to Post Earnings on Thursday

Annovis Bio (NYSE:ANVS) is expected to announce its earnings results on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.39) per share for the quarter.

Annovis Bio Stock Performance

ANVS stock opened at $1.84 on Thursday. Annovis Bio has a 1 year low of $1.53 and a 1 year high of $20.00. The firm has a market cap of $26.12 million, a P/E ratio of -0.41 and a beta of 1.65. The stock’s 50 day moving average price is $3.12 and its 200 day moving average price is $5.84.

Analyst Upgrades and Downgrades

Separately, D. Boral Capital reissued a “hold” rating on shares of Annovis Bio in a research note on Monday, February 10th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $37.00.

About Annovis Bio

Annovis Bio, Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases.